IXICO is pleased to announce that Cygnus, a real world digital data collection study from people with cognitive impairment and dementia, has joined the high profile Dementias Platform UK (DPUK).
The four NHS Trusts participating in the project have now initiated enrolment in the mehealth® digital technology platform which is being deployed for data collection and management. Consumer
wearable devices containing accelerometers will also be deployed to collect information on sleep and activity. The Cygnus study aims to advance the development of digital healthcare in patients with cognitive impairment and dementia and their caregivers.
By joining Dementias Platform UK, Cygnus is now part of a high profile collaborative project that includes leading academic centres and pharmaceutical companies GSK, AstraZeneca and Johnson &
Johnson. IXICO’s mehealth® platform is being used for data collection from participating services and patients and their caregivers. The mehealth® digital technology platform formed part of the Optimal Medicine acquisition in December 2015.